Global Early Toxicity Testing Market Overview 2023-2028
The global early toxicity testing market size reached US$ 1.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.9 Billion by 2028, exhibiting a growth rate (CAGR) of 8.2% during 2023-2028.
Preclinical toxicity testing, commonly referred to as early toxicity testing, plays a crucial role in drug development and the exploration of the therapeutic capabilities of existing compounds. Its primary objective is to assess the safety of substances and ascertain the compatibility of specific molecules with the human body. By aiding decision-making, saving resources, and reducing the abandonment of potential compounds, this testing methodology has gained widespread adoption in global industries such as chemicals, food and beverage (F&B), pharmaceuticals, and cosmetics.
Global Early Toxicity Testing Market Trends and Drivers:
Currently, the market is experiencing growth primarily due to the growing adoption of early toxicity testing, which plays a crucial role in ensuring the safety of food products intended for human consumption. Additionally, the use of early toxicity testing to mitigate the risk of drug candidate failures during clinical trials is also contributing to the market’s expansion. Furthermore, the cosmetic industry’s increasing reliance on early toxicity testing to assess the chemical composition of products is further driving market growth. Moreover, the market is propelled by the escalating demand for innovative and efficient treatment solutions, attributed to the rising prevalence of diverse diseases among the population.
Global Early Toxicity Testing Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are: Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Charles River Laboratories International Inc., Danaher Corporation, Enzo Biochem Inc., Eurofins Scientific SE, Evotec A.G., Merck KGaA, PerkinElmer Inc., SGS S.A., Thermo Fisher Scientific Inc. and WuXi AppTec.
The report has segmented the market on the basis of region, technique and end user.
Breakup by Technique:
• In Vivo
• In Vitro
• In Silico
Breakup by End User:
• Pharmaceuticals Industry
• Food Industry
• Chemicals Industry
• Cosmetics Industry
• Others
Breakup by Region:
• North America
o United States
o Canada
• Asia-Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Others
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Others
• Latin America
o Brazil
o Mexico
o Others
• Middle East and Africa
If you want the latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
• Market Performance (2017-2022)
• Market Outlook (2023- 2028)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800